Jump to content

Osteocalcin

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Neodop (talk | contribs) at 14:44, 12 June 2009. The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

bone gamma-carboxyglutamate (gla) protein (osteocalcin)
Identifiers
SymbolBGLAP
NCBI gene632
HGNC1043
OMIM112260
RefSeqNM_199173
UniProtP02818
Other data
LocusChr. 1 q25-q31
Search for
StructuresSwiss-model
DomainsInterPro

Osteocalcin is a noncollagenous protein found in bone and dentin. It is secreted by osteoblasts and thought to play a role in mineralization and calcium ion homeostasis. It has been stipulated that osteocalcin may also function as a negative regulator of bone formation, although its exact role is unknown.

In August 2007, it was reported[1] that osteocalcin acts as a hormone in the body, causing beta cells in the pancreas to release more insulin, and at the same time directing fat cells to release the hormone adiponectin, which increases sensitivity to insulin.

Use as a biochemical marker for bone formation

As osteocalcin is manufactured by osteoblasts, it is often used as a biochemical marker, or biomarker, for the bone formation process. It has been routinely observed that higher serum-osteocalcin levels are relatively well correlated with increases in bone mineral density (BMD) during treatment with anabolic bone formation drugs for osteoporosis, such as Forteo. In many studies, Osteocalcin is used as a preliminary biomarker on the effectiveness of a given drug on bone formation.

References